Vogl Thomas Josef, Wissniowski Thaddäus T, Naguib Nagy N N, Hammerstingl Renate M, Mack Martin G, Münch Sabine, Ocker Matthias, Strobel Deike, Hahn Eckhart G, Hänsler Johannes
Institute for Diagnostic and Interventional Radiology, Johann Wolfgang Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.
Cancer Immunol Immunother. 2009 Oct;58(10):1557-63. doi: 10.1007/s00262-009-0663-1. Epub 2009 Jan 29.
To asses if laser-induced thermotherapy (LITT) induces a specific cytotoxic T cell response in patients treated with LITT for colorectal cancer liver metastases.
Eleven patients with liver metastases of colorectal cancer underwent LITT. Blood was sampled before and after LITT. Peripheral T cell activation was assessed by an interferon gamma (IFNg) secretion assay and flow cytometry. Test antigens were autologous liver and tumor lysate obtained from each patient by biopsy. T cells were stained for CD3/CD4/CD8 and IFNg to detect activated T cells. The ratio of IFNg positive to IFNg negative T cells was determined as the stimulation index (SI). To assess cytolytic activity, T cells were co-incubated with human colorectal cancer cells (CaCo) and cytosolic adenylate kinase release was measured by a luciferase assay.
IFNg secretion assay: before LITT SI was 12.73 (+/-4.83) for CD3+, 4.36 (+/-3.32) for CD4+ and 3.64 (+/-1.77) for CD8+ T cells against autologous tumor tissue. Four weeks after LITT SI had increased to 92.09 (+/-12.04) for CD3+ (P < 0.001), 42.92 (+/-16.68) for CD4+ (P < 0.001) and 47.54 (+/-15.68) for CD8+ T cells (P < 0.001) against autologous tumor tissue. No increased SI was observed with normal liver tissue at any time point. Cytotoxicity assay: before LITT activity against the respective cancer cells was low, with RLU = 1,493 (+/-1,954.68), whereas after LITT cytolytic activity had increased to RLU = 7,260 [+/-3,929.76 (P < 0.001)].
Patients with liver metastases of colorectal cancer show a tumor-specific cytotoxic T cell stimulation and a significantly increased cytolytic activity of CD3+, CD4+ and CD8+ T cells after LITT against an allogenic tumor (CaCo cell line).
评估激光诱导热疗(LITT)在接受LITT治疗的结直肠癌肝转移患者中是否诱导特异性细胞毒性T细胞反应。
11例结直肠癌肝转移患者接受了LITT治疗。在LITT治疗前后采集血液。通过干扰素γ(IFNg)分泌试验和流式细胞术评估外周血T细胞活化情况。测试抗原为通过活检从每位患者获得的自体肝脏和肿瘤裂解物。T细胞用CD3/CD4/CD8和IFNg染色以检测活化的T细胞。IFNg阳性T细胞与IFNg阴性T细胞的比例被确定为刺激指数(SI)。为评估细胞溶解活性,将T细胞与人结肠癌细胞(CaCo)共同孵育,并通过荧光素酶测定法测量细胞溶质腺苷酸激酶释放量。
IFNg分泌试验:在LITT治疗前,针对自体肿瘤组织,CD3 + T细胞的SI为12.73(±4.83),CD4 + T细胞为4.36(±3.32),CD8 + T细胞为3.64(±1.77)。LITT治疗后4周,针对自体肿瘤组织,CD3 + T细胞的SI增加到92.09(±12.04)(P < 0.001),CD4 + T细胞为42.92(±16.68)(P < 0.001),CD8 + T细胞为47.54(±15.68)(P < 0.001)。在任何时间点,正常肝脏组织均未观察到SI增加。细胞毒性试验:在LITT治疗前,对相应癌细胞的活性较低,相对发光单位(RLU)= 1,493(±1,954.68),而LITT治疗后细胞溶解活性增加到RLU = 7,260 [±3,929.76(P < 0.001)]。
结直肠癌肝转移患者在LITT治疗后,针对同种异体肿瘤(CaCo细胞系)表现出肿瘤特异性细胞毒性T细胞刺激以及CD3 +、CD4 +和CD8 + T细胞的细胞溶解活性显著增加。